Cipla Inks Pact to Acquire 51% Stake in Yemeni Company

Continuing its overseas acquisitions, pharma major Cipla has inked a pact with a Yemeni firm to acquire majority of its stake for $21 million (over Rs 125 crore).

The company has signed a definitive agreement to acquire a 51 per cent stake in a pharmaceuticals manufacturing and distribution business in Yemen, it added.

"The company will pay$ 21 million for this transaction, with additional considerations to be paid over the next 3 years on achievement of agreed milestones," Cipla said.

Given the recent preference to local manufacturing, this secures the company's presence in a fast-growing market. Cipla already has a leading position in Yemen with over 200 products, it added.

As part of its global expansion, Cipla had completed the buyout of South African pharma firm Cipla Medpro for Rs 2,707 crore last year.

It had also acquired Croatia-based firm Celeris, distributor of its products in that country last December.

As of 13:01 p.m., shares in Cipla were trading at Rs 440.80 apiece on the BSE, up 0.80 per cent from the previous close.

Unlock this article for free
Sign up to access exclusive stories, fewer ads, and a personalised experience.
Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source